Position in CRMD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$581,977
-$419,098 QoQ
Shares Held
85,711
-0.4% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. CRMD ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in CRMD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $581,977 | 85,711 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,001,075 | 86,077 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,111,269 | 95,552 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,144,589 | 92,905 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $502,440 | 81,565 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $613,550 | 75,747 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $563,329 | 69,719 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $321,454 | 74,239 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $266,696 | 62,900 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $258,996 | 68,882 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $209,775 | 56,696 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $196,733 | 49,555 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $231,973 | 42,331 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $197,237 | 43,349 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $201,605 | 43,356 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $295,247 | 43,039 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $245,264 | 24,551 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $196,308 | 26,421 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $122,650 | 20,340 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $154,066 | 24,455 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $69,868 | 19,462 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||